Developing and Nationalizing Key Cannabis Research Act of 2022

Bill 117 HR 8540, also known as the Developing and Nationalizing Key Cannabis Research Act of 2022, aims to promote and facilitate research on cannabis by establishing a comprehensive framework for conducting studies on the plant and its derivatives. The bill seeks to address the current limitations and barriers that hinder scientific research on cannabis by streamlining the process for obtaining research permits and licenses.

One of the key provisions of the bill is the establishment of a National Cannabis Research Center, which will serve as a hub for coordinating and funding research projects related to cannabis. The center will also be responsible for collecting and disseminating data and findings from these studies to inform public policy and decision-making.

Additionally, the bill calls for the creation of a National Cannabis Research Advisory Board, comprised of experts in various fields such as medicine, public health, and law enforcement, to provide guidance and oversight on research priorities and funding allocations. The board will also be tasked with ensuring that research on cannabis is conducted in a safe and ethical manner. Furthermore, the bill includes provisions to support the development of standardized testing protocols for cannabis products, as well as guidelines for labeling and packaging to ensure consumer safety and transparency. It also calls for the establishment of a national registry of cannabis researchers and research projects to promote collaboration and information sharing within the scientific community. Overall, the Developing and Nationalizing Key Cannabis Research Act of 2022 aims to promote evidence-based policymaking and public health by expanding research opportunities and resources in the field of cannabis. By addressing the current barriers to research and promoting collaboration among researchers, the bill seeks to advance our understanding of cannabis and its potential benefits and risks.